CVE-2022-2139
The affected product is vulnerable to directory traversal, which may allow an attacker to access unauthorized files and execute arbitrary code.
Does this matter?
EPSS puts the probability of exploitation in the next 30 days at 16.0%, higher than 97% of all known CVEs. Patch or mitigate before the next change window.
Description
The affected product is vulnerable to directory traversal, which may allow an attacker to access unauthorized files and execute arbitrary code.
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 16.03% probability · 97th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-23, CWE-22
- Affected
- advantech/iview
- Source
- ics-cert@hq.dhs.gov
EPSS 16.0% since 26 October 2026; no change recorded yet. The dashed line is the ten per cent mark our analysts treat as “patch before the next change window”. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-179-03Third Party Advisory, US Government Resource
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-179-03Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.